Cargando…
Dendritic cell functional improvement in a preclinical model of lentiviral-mediated gene therapy for Wiskott-Aldrich syndrome
Wiskott-Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency caused by the defective expression of the WAS protein (WASP) in hematopoietic cells. It has been shown that dendritic cells (DCs) are functionally impaired in WAS patients and was(−/−) mice. We have previously demonstrated th...
Autores principales: | Catucci, Marco, Prete, Francesca, Bosticardo, Marita, Castiello, Maria Carmina, Draghici, Elena, Locci, Michela, Roncarolo, Maria Grazia, Aiuti, Alessandro, Benvenuti, Federica, Villa, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378501/ https://www.ncbi.nlm.nih.gov/pubmed/22189416 http://dx.doi.org/10.1038/gt.2011.202 |
Ejemplares similares
-
Autoimmunity in Wiskott–Aldrich Syndrome: An Unsolved Enigma
por: Catucci, Marco, et al.
Publicado: (2012) -
B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome
por: Castiello, Maria Carmina, et al.
Publicado: (2015) -
The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function
por: Locci, Michela, et al.
Publicado: (2009) -
Preclinical Safety and Efficacy of Human CD34(+) Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome
por: Scaramuzza, Samantha, et al.
Publicado: (2013) -
Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome
por: Sereni, Lucia, et al.
Publicado: (2019)